Header
Header
Article

New patent for Abbvie Inc drug ORILISSA – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Abbvie Inc drug ORILISSA


Annual Drug Patent Expirations for ORILISSA

Orilissa is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

ORILISSA drug price trends.

This drug has thirty-two patent family members in twenty-four countries.

The generic ingredient in ORILISSA is elagolix sodium. One supplier is listed for this compound. Additional details are available on the elagolix sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Abbvie Inc drug ORILISSA



Source link

Back to top button